Results 71 to 80 of about 213,380 (339)

Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Segmental tracheal resection is rarely needed for advanced thyroid cancer but is among the most complex, high‐risk thyroid surgeries. Methods Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005–2024).
Anastasios Maniakas   +19 more
wiley   +1 more source

Hubungan Ekspresi Sodium Iodide Symporter dengan Varian Histopatologi dan Stadium Papillary Thyroid Carcinoma

open access: yesMajalah Kedokteran Andalas
Abstrak                                                               Tujuan:  Mengetahui hubungan ekspresi sodium iodide symporter dengan varian histopatologi dan stadium papillary thyroid carcinoma.
Rini Purnama Sari   +5 more
doaj   +1 more source

Metachronous Follicular Variant of Papillary Thyroid Microcarcinoma in a Case of Medullary Carcinoma Thyroid [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2016
Medullary carcinoma and papillary thyroid carcinoma arise from the different cells. Simultaneous occurrence of both types is rare. Medullary carcinomas are characterised by calcitonin positivity.
Neelam Sood, Binit Kumar Khandelia
doaj  

Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer [PDF]

open access: yes, 2015
Anaplastic thyroid cancer (ATC) is often incurable so new therapeutic approaches are needed. Tyrosine kinases inhibitors (such as imanitib, sunitinib or sorafenib) are under evaluation for the treatment of ATC.
Bond JA   +11 more
core   +1 more source

miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10

open access: yesInternational Journal of Molecular Medicine, 2018
MicroRNAs (miRNAs) have important effects on cancer occurrence and development by adjusting gene expression. The aim of the present study was to examine the role of miR-214 in papillary thyroid carcinoma cell proliferation and metastasis, and its ...
Fang-zhou Liu   +8 more
semanticscholar   +1 more source

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2022
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most ...
R. Haddad   +35 more
semanticscholar   +1 more source

Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi‐Center Retrospective Cohort

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Brain metastases (BM) of differentiated thyroid carcinoma (DTC) are associated with unfavorable prognosis. This study evaluated BM management strategies and patients' outcomes. Methods A retrospective review of patients diagnosed with DTC and BM at Tel Aviv Sourasky and Rabin Medical Centers between 1985 and 2024. Clinical features,
Liyona Kampel   +9 more
wiley   +1 more source

Unusual Presentation of Cystic Papillary Thyroid Carcinoma

open access: yesCase Reports in Endocrinology, 2012
Papillary thyroid carcinoma is the most common thyroid malignancy, accounting for 80% of all thyroid cancers. The most common presentation of thyroid cancer is an asymptomatic thyroid mass or a nodule.
Vijayraj S. Patil   +2 more
doaj   +1 more source

Tumor‐Intrinsic Forkhead Box A2 Regulates the Lymph Node Metastasis of Papillary Thyroid Carcinoma by Regulating T‐Cell Apoptosis

open access: yesiLABMED, EarlyView.
We identified FOXA2 as a key regulator of lymph node metastasis in thyroid cancer, which controls cancer cell aggressiveness. FOXA2 knockdown promotes metastasis by enhancing tumor cell migration and, importantly, by inducing T‐cell apoptosis through a CCL2/LCN2‐mediated pathway. Created with BioGDP.com.
Ping Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy